Carlo Colosimo

Santa Maria Nuova Hospital — Italy

Medicine · Health Sciences

65h-index19.6kcitations374works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurological disorders and treatments(178), Parkinson's Disease Mechanisms and Treatments(175), Botulinum Toxin and Related Neurological Disorders(101), Genetic Neurodegenerative Diseases(62), Parkinson's Disease and Spinal Disorders(28)

Publications365 total

A European perspective on tardive dyskinesia
European Neuropsychopharmacology·2025Open Access
A Short Version of Carers' Quality of Life Questionnaire for Parkinsonism: Data from Progressive Supranuclear Palsy Network
Movement Disorders Clinical Practice·2025Open Access
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE)
The Journal of Headache and Pain·2025· 2 citedOpen Access
The “gunslinger” sign in neurological disorders
Journal of the Neurological Sciences·2025
It Is Time for Drug Repurposing in Parkinson Disease
Neurology·2025Open Access
Lecanemab e la malattia di Alzheimer-Perusini: tra speranze terapeutiche e sfide regolatorie
Recenti Progressi in Medicina·2025
Correction: RT-QuIC: a highly promising diagnostic method for neurodegenerative diseases—advantages and limitations
Frontiers in Neurology·2025· 1 citedOpen Access
RT-QuIC: a highly promising diagnostic method for neurodegenerative diseases—advantages and limitations
Frontiers in Neurology·2025· 3 citedOpen Access
Fluid biomarkers in atypical Parkinsonism: current state and future perspectives
Journal of Neural Transmission·2025· 2 cited
Concerns about the approval of lecanemab for Alzheimer’s disease
BMJ·2025· 4 citedOpen Access
Do Parkinson’s Disease clinical subtypes really exist?
Neurologia i Neurochirurgia Polska·2025· 5 citedOpen Access
Diagnosis and management of tardive dyskinesia: from research to clinical practice
Rivista di psichiatria·2025· 1 citedOpen Access
Oxidative Stress: A New Pathophysiological Pathway in Parkinson’s Disease and a Potential Target of the Brain‐Sport Crosstalk
Parkinson s Disease·2025· 10 citedOpen Access
Can We Better Predict the Timing for Medication Initiation in Early <scp>PD</scp>?
Movement Disorders Clinical Practice·2024Open Access
The Gunslinger’s sign in atypical parkinsonism
Journal of the Neurological Sciences·2024
Family History in Parkinson's Disease: A National Cross‐Sectional Study
Movement Disorders Clinical Practice·2024· 5 citedOpen Access
Dropped Head Syndrome: The Importance of Neurophysiology in Distinguishing Myasthenia Gravis from Parkinson’s Disease
Biomedicines·2024· 1 citedOpen Access
Issue Information
Movement Disorders Clinical Practice·2024Open Access
Issue Information
Movement Disorders Clinical Practice·2024Open Access
Reply to: Questioning the cycad theory of Kii ALS–PDC causation
Nature Reviews Neurology·2024· 1 citedOpen Access
page 1 of 19Next →

Frequent Co-authors

Gregor K. Wenning(15), G. Meco(14), Werner Poewe(13), Angelo Antonini(10), Paolo Barone(10), Alberto Albanese(10), Giovanni Fabbrini(10), Klaus Seppi(9), Alfredo Berardelli(9), Cristina Sampaio(8), Niall Quinn(7), Francesca Morgante(7), Anette Schrag(7), Wolfgang H. Oertel(7), Thomas Klockgether(6), Günter U. Höglinger(6), Irene Litvan(6), Felix Geser(6), Maria Teresa Pellecchia(6), Christer Nilsson(6)